Article Sidebar
Article Details
The entire contents of the Tropical Journal of Obstetrics and Gynaecology are protected under Indian and international copyrights. The Journal, however, grants to all users a free, irrevocable, worldwide, perpetual right of access to, and a license to copy, use, distribute, perform and display the work publicly and to make and distribute derivative works in any digital medium for any reasonable non-commercial purpose, subject to proper attribution of authorship and ownership of the rights. The journal also grants the right to make small numbers of printed copies for their personal non-commercial use.
This journal content is distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
Main Article Content
The role of a parenteral multivitamin preparation (Eldervit-12® in the prevention of anaemia in pregnancy
Abstract
Objective: To determine if the administration of a parenteral multivitamin preparation (Eldervit 12 R) in pregnancy is effective in reducing the prevalence of anaemia in pregnancy.
Materials and Methods: A prospective, randomized controlled trial using patients pooled into study and control groups receiving Eldervit-12 injections and oral multivitamin preparations respectively. One hundred patients were recruited into each group. Baseline Haemoglobin concentration and reticulocyte count were done at the time of recruitment and repeated at 36 weeks gestation.
Results: The changes from baseline to final value in the Haemoglobin concentration (9.7-11.7g/dl) and reticulocyte count (2.1-3 %) were higher in the study than in the control group (9.8-10g/dl and 2.2-3 % respectively). The final Haemoglobin concentration and reticulocyte count of the study group (11.7 g/dl and 5.3 % respectively) were significantly higher than in the control group (10.0 g/dl and 3.0 % respectively). In the study group 9.7% of patients were anaemic (WHO Definition) while in the control group 75% remained anaemic at 36 weeks gestation. Overall the drug was well tolerated.
Conclusion: This study suggests that the use of Eldervit-12 in pregnancy can significantly reduce the prevalence of anaemia in the later stages of pregnancy.
Keywords: anaemia, pregnancy, Eldervit-12 injection, haemoglobin, reticulocytes
Tropical Journal of Obstetrics and Gynaecology Vol. 22(2) 2005: 159-163
